This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Trials Europe
29 - 30 November, 2023
CCIB, Barcelona

Isabelle Naeije
Associate Global Trial Director at Novartis, Switzerland


Isabelle Naëije has a Master in Sciences degree in bio-engineering (Free University of Brussels, Belgium). She works for Novartis Pharma AG, Basel, Switzerland. She is an Assoc. Global Trial Director overseeing clinical trials (phase I to IV, oncology). She is currently assigned to two trials in radio ligand therapy (Glioblastoma and Small Cell Lung Cancer). In parallel, she is a patient engagement champion, bringing the voice of the patients at each step of the clinical development. She was part of the IMI PREFER workstream (Innovative medicine initiative, Patient Preferences in benefit risk assessments during the drug life cycle). Before taking this role at Novartis, she worked at Actelion Pharmaceuticals Ltd, Switzerland in the Clinical Pharmacology department. She came to Switzerland in 2011 after 5 years spent as Global Study Manager at Glaxo SmithKline Biologicals, Belgium. Prior to moving to the pharmaceutical industry, she worked as on-site clinical Research Assistant at the Erasmus University Hospital, Belgium. I

Agenda Sessions

  • Chairperson Opening Comments

  • PANEL: Develop Long-Lasting Relationships that Strengthen Patient Involvement and Embeds them into Business Decision Making